Albert Bourla, Pfizer CEO (Efren Landaos/Sipa USA/Sipa via AP Images)
US set to pay nearly $2B for Pfizer's Covid-19 treatment Paxlovid in 2023
The US government is teeing up more Pfizer Covid-19 antiviral purchases for next year – to the tune of $2 billion.
Pfizer’s new agreement with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
